TABLE 3.

Moderation Effects on the Primary Outcomes Over 6 Months

	Effect on HbA1c coefficients ± SE		Effect on overall quality of life (total PedsQL) coefficients ± SE		Effect on quality of life for diabetes (DAIBMOD) coefficients ± SE
	TEENCOPE	Managing diabetes	TEENCOPE	Managing diabetes	TEENCOPE	Managing diabetes
Gender
Male	0.27 ± 0.27	0.39 ± 0.28	1.78 ± 0.73	2.09 ± 0.68	0.70 ± 1.07	4.19 ± 1.01
Female	0.24 ± 0.26	0.57 ± 0.27	0.76 ± 0.62	1.31 ± 0.60	1.45 ± 0.92	1.03 ± 0.89
Difference by gender (p)	.9255	.5745	.2914	.3936	.5962	.0199a
Income
High income ($60,000+)	0.06 ± 0.23	0.35 ± 0.23	1.01 ± 0.58	1.77 ± 0.54	0.50 ± 0.86	2.77 ± 0.79
Low income (<$60,000)	0.66 ± 0.33	0.83 ± 0.36	1.56 ± 0.82	1.37 ± 0.84	2.42 ± 1.22	1.58 ± 1.25
Difference by income (p)	.1286	.2407	.5845	.6893	.2001	.4233
Child age (years)
Older (11–12)	0.26 ± 0.24	0.65 ± 0.25	2.00 ± 0.81	1.03 ± 0.67	2.33 ± 1.20	1.46 ± 1.00
Younger (13–14)	0.24 ± 0.30	0.26 ± 0.31	0.77 ± 0.58	2.16 ± 0.61	0.51 ± 0.87	3.19 ± 0.90
Difference by child age (p)	.9402	.3764	.2190	.2138	.2224	.2005
Therapy type
Injection	−0.04 ± 0.31	0.62 ± 0.32	1.14 ± 0.76	1.67 ± 0.73	1.32 ± 1.13	2.98 ± 1.09
Pump	0.43 ± 0.24	0.41 ± 0.25	1.22 ± 0.61	1.64 ± 0.57	1.02 ± 0.90	2.07 ± 0.85
Difference by therapy (p)	.2214	.6816	.9325	.9710	.8375	.5121
Race
White, non-Hispanic/non-Latino	0.33 ± 0.23	0.45 ± 0.25	0.74 ± 0.57	1.41 ± 0.56	0.28 ± 0.85	2.25 ± 0.83
Black/other ethnicity	0.09 ± 0.33	0.55 ± 0.32	2.17 ± 0.84	2.10 ± 0.76	3.01 ± 1.25	2.72 ± 1.12
Difference by race (p)	.5455	.7378	.1625	.4608	.0728	.7414
Depression
Low depression (CDI < 12)	0.27 ± 0.20	0.43 ± 0.21	0.27 ± 0.50	1.55 ± 0.48	0.39 ± 0.76	2.12 ± 0.72
High depression (CDI ≥ 12)	0.12 ± 0.51	0.67 ± 0.47	6.86 ± 1.25	2.23 ± 1.17	5.75 ± 1.88	4.13 ± 1.77
Difference by depression (p)	.7798	.6448	<.0001a	.5932	.0090a	.2943

Note. CDI = Children’s Depression Inventory.

^aSignificant moderation effect.